PORTRAIT – A multi-omic stratification and a non invasive tool for early recognition of triple negative and Her2+ breast cancer patients responders to neoadjuvant therapy
ERA PerMed is a new ERA-Net Cofund, supported by 32 partners from 23 countries and cofunded by the European Commission. To align national research strategies, promote excellence, reinforce the competitiveness of European players in PM, and enhance the European collaboration with non-EU countries, national funding organisations have agreed to launch Joint Transnational Calls for collaborative innovative research projects in Personalised Medicine (PM).
- Researcher: Josefa León López
- Group: MP15-Enfermedades Hepáticas y Cáncer Colorrectal
- Center: Hospital Universitario Clínico San Cecilio
- Rol in the project: Project Partner
- Duration: 2023 – 2026
Página web del proyecto: https://erapermed.isciii.es/